Does insurance cover Ozempic®? Check your coverage in 2026

If you’ve been prescribed Ozempic^® or you’re thinking about asking your doctor for it, one of the first questions that probably comes to mind is: Will my insurance actually pay for this?

It’s a fair question—and an important one. Without insurance, Ozempic® is known for being an expensive medication with a list price of just over $1,000. Designed for diabetes management, Ozempic^®, made with the active ingredient semaglutide, also gained a lot of attention for helping people lose weight off-label.

Whether insurance will cover Ozempic® can be a different answer depending on why it was prescribed, what type of plan you have, and, in some cases, what documentation your doctor provides. With a list price hovering around $1,027 per month, understanding coverage options can be essential for many people before they start taking it.

Let’s take a look at when Ozempic® is covered, what it is covered for, what you’ll pay for it with and without insurance, and some important alternatives if weight loss is your primary goal.

Is Ozempic^® ever covered by insurance?

Sometimes. Some insurance plans do cover Ozempic^®, but typically only under certain conditions. The most common path to coverage is a type 2 diabetes diagnosis. If your doctor prescribes Ozempic^® specifically for blood sugar management, there’s a chance your plan might cover it, though you might have to meet certain requirements before it’s approved

If you’re prescribed Ozempic® off-label for weight loss, coverage is unlikely—and there are two main reasons why.

• First, Ozempic® isn’t FDA-approved for weight loss. It’s approved for type 2 diabetes, so when it’s prescribed off-label for weight management, many insurers either restrict coverage or deny it altogether.
• Second, even when a medication is FDA-approved for weight loss—like Wegovy®, which contains the same active ingredient—insurance coverage still isn’t guaranteed. That’s because insurers aren’t required to cover medications used solely for weight loss. As a result, coverage varies widely by plan, and many exclude these drugs entirely.

Ozempic® is less likely to be covered for weight loss because it’s off-label for that use—but even approved options like Wegovy® often face limited or no coverage depending on your insurance plan.

Before approving coverage for diabetes, plans commonly ask for:

• Prior authorization (PA): Your provider submits a detailed request explaining why Ozempic^® is medically appropriate for you. This is one of the most common requirements across all plan types.
• Recent lab work or clinical notes: Blood sugar results, A1C levels, and other clinical records that support the medical need for the medication.
• Proof that other medications haven’t worked: Many plans require proof that metformin was tried and either not tolerated or that it did not get A1c to the desired goal.

For a closer look at what to expect while taking the medication, you can learn more about potential side effects here: Ozempic^® side effects.

How Ozempic® coverage differs by plan type: Private, Medicare, and Medicaid

The same Ozempic^® prescription can be covered easily under one plan and hit a wall under another. That’s because Medicare, Medicaid, and private plans all play by different rules.

Private and employer-sponsored plans

This is where coverage varies the most. Some employer plans include robust weight management benefits and may cover Ozempic^® with prior authorization when it’s prescribed for type 2 diabetes treatment, but they’re still unlikely to cover it for weight loss. If a plan does include coverage for weight loss medications, it’s more likely to cover Wegovy^® since Wegovy^® is FDA-approved for that purpose. 

Drug tier placement matters too—even if Ozempic^® is covered, being placed on a specialty tier can mean significantly higher out-of-pocket costs. Checking your formulary and benefits summary is the best way to understand what your specific plan allows.

Medicare

Traditional Medicare drug coverage comes through Part D plans, which are run by private insurers approved by Medicare. For type 2 diabetes, Ozempic^® is generally covered under many Part D plans. It wouldn’t be covered for weight loss because federal law prevents Medicare from covering medications prescribed specifically for weight loss. 

That could change in the future. A CMS pilot program (Centers for Medicare & Medicaid Services) expected to launch in mid-2026 may expand access to GLP-1 medications for weight loss, though again, that would apply to Wegovy®, not Ozempic®. 

Plus, plans will need to opt in, so not all Part D or Medicare Advantage plans will participate. Each Part D plan also sets its own formulary, drug tiers, and PA requirements, so copays and out-of-pocket costs can vary.

Medicaid

Medicaid programs are managed at the state level, which means coverage rules depend on where you live. Most state programs cover Ozempic^® for type 2 diabetes on their preferred drug lists. Weight management coverage through Medicaid is far less consistent—some states restrict or exclude it entirely, while others allow it with prior authorization. And, when medication is covered, usually it’s Wegovy^® and not Ozempic^®. Each state also sets its own documentation requirements and step therapy rules.

What insurance covers Ozempic^®?

Coverage for Ozempic^® can feel confusing. Two people with the same prescription can have wildly different experiences depending on their insurer, employer, or even the state they live in. Here’s a look at how major insurers typically handle Ozempic^® coverage.

Ozempic^® coverage: Private insurance plans 

Ozempic^® coverage often depends on the fine print of your insurance plan. Insurers rely on their own approved drug lists, called formularies, to determine whether a medication is covered and what conditions need to be met before they’ll cover it. Because Ozempic^® is FDA-approved for type 2 diabetes but frequently prescribed off-label for weight loss, coverage can hinge on your diagnosis and how your provider documents it. The breakdown below highlights how major insurers tend to handle Ozempic^®, including typical requirements like prior authorization, though the exact details can vary by plan and location.

• PA – This drug requires prior authorization 
• QL – This drug has quantity limits

Insurance provider	Coverage status	Requirements	Comments	State variation
Aetna	Covered for type 2 diabetes. Weight management coverage, if included, would apply to Wegovy®.Ozempic® is usually listed in the Preferred Brand tier, which carries higher copays than Aetna’s lower-cost Preferred Generic tier.	PA required. QL common. BMI documentation needed for weight management.	Pharmacy benefits often managed through CVS Caremark.	Yes
Blue Cross Blue Shield (BCBS)	Varies by state affiliate. Diabetes coverage is more consistent across plans.	PA is frequently required. Step therapy may apply for weight management for Wegovy®.	Each state BCBS affiliate sets its own formulary and rules.	Yes
Cigna	Generally covered for type 2 diabetes under most formularies. Weight management coverage is plan-dependent and would likely apply to Wegovy®.	PA and QL are standard. Clinical documentation required.	Some employer plans exclude weight management drugs entirely.	Yes
UnitedHealthcare	Listed on most formularies for diabetes. Weight management coverage varies by employer group and would likely apply to Wegovy®.	PA required. Step therapy and BMI documentation often needed.	OptumRx handles pharmacy benefits. Coverage rules shift annually.	Yes
Kaiser Permanente	Covered for type 2 diabetes within Kaiser formulary. Weight management policies vary by region and would likely apply to Wegovy®.	Internal PA process. Lab work and clinical documentation expected.	Kaiser uses its own pharmacy system, so formulary is tightly managed.	Yes
Humana	Available on many Humana formularies for diabetes. Weight management coverage varies and would likely apply to Wegovy®.	PA and QL common. Prior documentation of lifestyle intervention may be required.	Humana Medicare Advantage plans follow Part D rules for Ozempic.	Yes
Anthem	Covered only for diabetes.	PA required. Diagnosis documentation needed.	Anthem affiliates operate under different names in various states.	Yes
Molina Healthcare	State-dependent. Generally available for type 2 diabetes with PA.	PA required. Step therapy may apply. Formulary varies by state Medicaid contract.	Primarily serves Medicaid and marketplace populations.	Yes
Ambetter	Coverage varies by state marketplace plan. Diabetes coverage only.	PA and QL are typical. Step therapy may apply.	Managed by Centene. State-level variation is significant.	Yes
Oscar Health	Listed on some formularies for diabetes. Weight management coverage is limited and would likely apply to Wegovy®.	PA required. Clinical documentation and BMI records needed.	Smaller plan footprint. Coverage may differ by state.	Yes
CVS Caremark (PBM)	Formulary inclusion depends on the employer or plan sponsor. Diabetes use is more broadly included.	PA and step therapy managed by CVS Caremark on behalf of the plan.	CVS Caremark is a PBM, not an insurer. Rules are set by the plan sponsor.	Yes
Express Scripts (PBM)	Listed on many managed formularies for diabetes. Weight management access depends on the plan sponsor and would likely apply to Wegovy®.	PA, QL, and step therapy are commonly applied.	Express Scripts manages benefits for Cigna and other large plans. Publishes annual exclusions list.	Yes

The information above reflects publicly available plan data as of March 2026. Coverage can change, so always double-check your plan’s formulary for the latest details.

Ozempic^® coverage: Federal & Medicare insurance plans

Coverage for Ozempic^® works a bit differently under federal health programs than it does with private insurance. Programs like Medicare and TRICARE follow their own guidelines when deciding which medications they’ll cover and under what circumstances. Ozempic^® might be covered when prescribed for type 2 diabetes. Weight loss coverage isn’t permitted. 

The chart below breaks down how these programs typically approach coverage, including common approval criteria and requirements, though specifics can still vary by plan.

Insurance provider	Coverage status	Requirements	Comments	State variation
Medicare (Part D)	Covered for type 2 diabetes under most Part D plans.	Formulary placement varies. Copays depend on drug tier and deductible status.	CMS pilot program for weight management coverage expected to begin mid-2026.	No (federal)
Tricare	Covered for type 2 diabetes.	PA required for most GLP-1 medications. Documentation of medical necessity is needed.	Military beneficiaries should check the Tricare formulary search tool.	No (federal)

Ozempic^® coverage: State Medicaid insurance plans

Medicaid coverage for Ozempic^® can look different depending on your state. Since each state runs its own Medicaid program, decisions about which medications are covered—and under what conditions—aren’t the same across the country. Ozempic^® is generally more likely to be covered when prescribed for type 2 diabetes, but requirements like prior authorization or step therapy can still apply.

Insurance provider	Coverage status	Requirements	Comments	State variation
Medicaid	Many state programs cover type 2 diabetes. Weight management coverage varies by state and would likely apply to Wegovy®.	State-specific PA and step therapy rules. Preferred drug lists vary.	Coverage is determined at the state level. Contact your state Medicaid office.	Yes

Check out our complete dosage guide for a more in-depth look at how Ozempic^® dosing works: Ozempic^® dosage guide.

State-by-state coverage for Ozempic^®

Where you live can quietly shape what you pay at the pharmacy. This is especially true with Medicaid, since each state runs its own program and sets its own drug rules. Over the past year, several states have updated their coverage policies for GLP-1 medications, including Ozempic^®.

Here’s a look at some notable state-level differences:

State	What’s different here?
California	Medi-Cal covers Ozempic® for type 2 diabetes. As of early 2026, weight management-only coverage has become more restricted, with some managed care organizations removing GLP-1s for weight loss from preferred drug lists.
New York	Medicaid covers Ozempic® for type 2 diabetes. Weight management access through Medicaid managed care plans may require PA and documented BMI criteria, and would apply to Wegovy®. Coverage rules can vary between managed care organizations.
Texas	Medicaid covers diabetes with PA. Weight management coverage through Medicaid is not available.
Florida	Medicaid covers Ozempic® for diabetes. Weight-loss-only prescriptions face significant restrictions and would likely apply to Wegovy®.
Pennsylvania	As of January 2026, Medicaid weight-loss-only coverage for certain GLP-1s has been restricted. Diabetes coverage remains available with PA.
Illinois	Medicaid covers for type 2 diabetes. Weight management coverage through Medicaid is available in some managed care plans with PA and documented medical necessity and would likely apply to Wegovy®.

Coverage information may vary and change frequently. Always confirm with your state Medicaid office or insurance provider.

What determines coverage?

Behind every approval or denial is a set of criteria that your insurer checks before agreeing to pay. Understanding these factors can help you see why two people with similar prescriptions may end up with completely different coverage outcomes.

Key factors include:

• The FDA label: Plans typically anchor their decisions to the drug’s official FDA-approved indications. 
• Clinical documentation: Reviewers look at what’s in your medical chart, including your diagnosis code, BMI (if relevant), lab results like A1C or fasting glucose, and notes about your medical history. The more thorough and specific your records are, the better your chances of approval.
• Prior authorization requirements: Ozempic^® almost always requires PA. Your provider submits clinical information explaining why this specific medication is the right choice. If the insurer decides the documentation is incomplete or doesn’t meet their criteria, the PA can be denied—though you can appeal.
• Benefit design exclusions: Some plans exclude medications entirely. In those cases, coverage isn’t decided by your medical record but by the structure of the plan itself.
• Preferred drug lists (formularies): Even within covered categories, your plan has a list of preferred drugs. Ozempic^® might not always be the preferred GLP-1. Some plans may cover tirzepatide (Mounjaro^®) instead for diabetes. You can explore how Ozempic^® and tirzepatide compare in terms of effectiveness and cost here: Ozempic^® vs. Mounjaro®.
• Medicare policy changes: CMS has been actively working on expanding access to GLP-1 medications for weight management within Medicare. A pilot program expected to launch in mid-2026 could allow qualifying beneficiaries to access Ozempic^® at a $50 monthly copay, but this wouldn’t be for weight loss. Additionally, starting in January 2027, negotiated Medicare prices will bring the monthly cost of Ozempic^® down under Part D.

All of these factors work together during the review process, and outcomes can vary widely from one plan to another.

How to check if your insurance covers Ozempic^®

Most plans publish their drug lists online, but the information is often spread across multiple documents. Here’s a simple checklist to help you figure out where you stand:

• Call the member services number on your insurance card
  Ask if Ozempic^® is included under your pharmacy benefit and what conditions it’s covered for. Since Ozempic® is primarily approved for type 2 diabetes, it’s helpful to confirm which diagnoses qualify. You can also request a copy of your plan’s formulary or a link to it—many insurers make this available online through their member portal. For example, Medicare Part D plans publish updated formularies each year.
  
• Ask about prior authorization (PA)
  Even if your insurance does cover Ozempic^®, many plans require prior authorization. This means your provider will need to submit documentation showing the prescription is medically necessary. Ask what details are required, such as diagnosis codes, lab results, or treatment history.
  
• Check for step therapy requirements
  Some insurance plans apply step therapy rules. This means you may need to try other medications—like metformin or other diabetes treatments—before Ozempic^® will be approved. It’s worth asking whether your plan has this requirement and what needs to be tried first.
  
• Confirm BMI and medical eligibility criteria
  Coverage for weight management medications usually requires documentation showing:
  • BMI ≥30, or
  • BMI ≥27 with a weight-related health condition, such as high blood pressure or high cholesterol.

The exact criteria and documentation requirements can differ depending on the insurer and, for Medicaid plans, the state program.

• Review Medicare or Medicaid rules (if applicable)
  • Traditional Medicare Part D typically covers Ozempic^® when it’s prescribed for type 2 diabetes, but not for weight loss alone.
  • Medicaid coverage is more variable—most state programs cover Ozempic^® for diabetes, but prior authorization or step therapy is often required.
    
• Use official coverage tools
  Novo Nordisk offers resources that can help you understand potential coverage options and savings opportunities for Ozempic^®.
  
• Get everything in writing
  If your insurance approves or denies coverage—or asks for more information—request written confirmation. Having documentation can be helpful if you need to file an appeal later.

If your plan doesn’t cover Ozempic^® but does cover another medication in the same category, it may be worth comparing alternatives to see what’s accessible under your plan. See how Ozempic^® and tirzepatide compare here: Ozempic^® vs Mounjaro^®.

Cost of Ozempic^® with and without insurance

The out-of-pocket cost for Ozempic^® depends on your insurance coverage, the dose prescribed, and whether you’re using pharmacy coupons or manufacturer programs. The list price for the standard weekly injection is around $1,028 per month. Many people with commercial insurance can lower that cost significantly using insurance benefits and the Novo Nordisk savings card. Even without insurance, Novo Nordisk’s cash-pay pricing offers a substantial discount compared with the full retail price.

Ozempic^®: Costs with insurance

When Ozempic^® is covered under a plan, typical out-of-pocket costs range from roughly $25 to $150 per month, though your exact amount will depend on your specific insurance design and pharmacy benefits. Coverage placement—like the formulary tier—can influence whether you pay a flat copay or a percentage of the cost (coinsurance). Lower-tier placement generally translates to smaller monthly payments, while higher tiers may increase out-of-pocket expenses.

Additional factors that can affect cost include:

• Deductible status: If you’re in a high-deductible health plan, you may pay more until your deductible is met. After that, your costs usually drop to standard copay or coinsurance amounts.
  
• Prior authorization approval: Most insurers require documentation from your provider showing that Ozempic^® is medically necessary. Once approved, coverage follows your plan’s cost-sharing rules.
  
• Prescribed dose: Ozempic^® injections are titrated gradually, and higher doses may be priced differently or placed on a different formulary tier.
  
• Prescription length: Filling a 90-day supply may lower the per-month cost compared to a 30-day supply.

While $25 to $150 per month is a commonly cited range, actual costs may vary based on deductible status, dose, plan design, and whether manufacturer savings programs apply.

In February 2026, the manufacturer, Novo Nordisk, announced that the list price of Ozempic^® (0.5 mg, 1 mg, and 2 mg doses) will be reduced by about 50% to $675 per month starting January 1, 2027. This new price will take effect alongside new negotiated Medicare prices of $274 per month under the Inflation Reduction Act, resulting in lower costs for both individuals using insurance and people who pay cash.

Understanding the Ozempic^® Savings Card

If your commercial insurance covers Ozempic^®, the Novo Nordisk savings card can reduce your monthly copay to as little as $25 per fill, subject to a maximum savings cap of of $100 per month for up to 48 months. Note that this savings card can only be used by those with commercial insurance that covers it, and can’t be used by those with Medicare, Medicaid, or Tricare.

• How it works: After your insurance pays its share, the discount is applied at the pharmacy, usually reducing your copay to about $25 per month, depending on your exact plan.
  
• Who qualifies: People with commercial (non-government) insurance whose plans already cover Ozempic^®.
  
• Who isn’t eligible: Those with Medicare, Medicaid, TRICARE, VA, or other government-funded insurance.
  
• How to use it: Enroll in the official Novo Nordisk program, download the card, and present it at the pharmacy alongside your insurance.

Even with the savings card, your actual cost depends on plan rules, pharmacy benefit design, and monthly savings limits.

Patient Assistance Program (PAP)

If you meet certain income requirements, Novo Nordisk’s Patient Assistance Program may provide Ozempic^® at no cost. Eligibility generally requires household income at or below 400% of the federal poverty level for insured people, or 200% for uninsured people. Note that Medicare Part D recipients are no longer eligible for the PAP as of 2026.

Ozempic^®: Costs without insurance

If paying fully out-of-pocket, Ozempic^® injections cost around $1,028 per month at traditional retail pharmacies. Many people now use Novo Nordisk’s reduced self-pay pricing, which can make treatment more affordable:

Ozempic^® injection (weekly pens)

• 0.25 mg and 0.5 mg: $199 for the first two fills, then $349/month
  
• 0.25 mg and 0.5 mg (after the first 2 fills) and 1 mg: $349/month
  
• 2 mg: $499

For a detailed breakdown of costs by dosage, plan type, and self-pay options, see Ozempic® cost guides and dosage information.

For a full cost comparison across dosing and coverage scenarios, check out our detailed cost guides: Ozempic^® cost, Ozempic^® cost without insurance, and Ozempic^® dosage guide.

Frequently asked questions about insurance coverage for Ozempic^®

Why is Ozempic^® often not covered by insurance?

Coverage decisions usually come down to the rules written into your specific plan. Most plans only approve Ozempic^® when used for type 2 diabetes. Since Ozempic^® isn’t FDA-approved for weight loss, it is rarely covered for that purpose. 

Plus, many plans exclude weight management medications entirely as a benefit category since insurance plans aren’t required to cover weight loss medications, and if a plan does cover them, it’s more likely to cover Wegovy^® since it’s approved for weight loss. 

Even if Ozempic^® is technically on the formulary, a denial can happen if the documentation your provider submits doesn’t meet the insurer’s requirements for medical necessity. In some cases, plans may prefer a different GLP-1 medication and require step therapy before covering Ozempic^®.

How can I get insurance to cover Ozempic^®?

The best approach is to make sure your medical record clearly supports the request. That means a documented diagnosis for type 2 diabetes, recent lab work like A1C results, and notes showing you’ve discussed or tried other treatments like metformin. Your doctor submits this through the prior authorization process. If coverage is denied, you have the right to appeal—and a well-documented appeal with additional clinical justification can sometimes overturn the initial decision.

How much is Ozempic^® with insurance coverage?

Private (commercial) insurance:

Many people pay between $25 and $150 per month, depending on the plan’s drug tier and whether they’ve met their deductible. Eligible patients can use the Novo Nordisk Savings Card, which can lower the copay to as little as $25 per month.

Medicare (Part D):

Costs vary depending on the plan’s formulary and coverage rules. For 2026, the out-of-pocket maximum for all Part D prescriptions is $2,100 per year. The savings card isn’t available for people on Medicare.

Medicaid:

Coverage differs by state and program. Some states cover Ozempic^® for type 2 diabetes, while others may require prior authorization. Out-of-pocket costs are generally very low, but eligibility and rules vary depending on the state program.

How do I get Ozempic^® for $25?

The $25 price typically comes from combining commercial insurance coverage with the Ozempic^® Savings Card from Novo Nordisk. The card covers up to $100 per monthly fill, which brings many commercially insured people to the $25 mark. You’ll need active insurance coverage for Ozempic^® and to meet the card’s eligibility criteria. Government insurance (Medicare, Medicaid, Tricare) doesn’t qualify.

What is the most affordable way to get Ozempic^®?

For commercially insured people, the Savings Card, plus plan coverage, is the lowest-cost route. 

For cash-paying people, the Novo Nordisk self-pay pricing through NovoCare Pharmacy offers the best structured pricing: $199 to $499 per month, depending on dose. The Patient Assistance Program can provide Ozempic^® at no cost for those who meet income eligibility requirements.

How much weight can you lose on Ozempic^® in 3 months?

Clinical trials suggest that people taking semaglutide (the active ingredient in Ozempic^®) can lose roughly 5 to 8% of their body weight within the first three months. Individual results vary based on factors like starting weight, dosage, diet, exercise, and overall health. Keep in mind that Ozempic^® is FDA-approved for diabetes management, not weight loss—Wegovy® is approved for weight loss and goes up to a higher dose.

How much is Ozempic^® if my insurance won’t pay for it?

Without any insurance coverage, the list price for Ozempic^® is approximately $1,027 per month. Through Novo Nordisk’s self-pay program, prices range from $199 to $499 per month, depending on dose and eligibility. 

The bottom line: Ozempic^® coverage depends on the plan and diagnosis

Insurance coverage for Ozempic® often comes down to the details: your diagnosis, what’s documented in your chart, prior authorization requirements, and whether your plan includes it. Some people are approved with minimal friction, while others may face denials that require appeals or alternative options.

The landscape is also evolving. Expanded self-pay pricing from Novo Nordisk, new Medicare pilot programs, and a planned list price reduction to $675 in 2027 are steps toward improving access. In the meantime, savings cards, patient assistance programs, and prescription discount tools can help reduce out-of-pocket costs.

If your plan doesn’t cover Ozempic, there are still options to consider. Discuss alternatives with a healthcare provider, compare pricing across pharmacies and programs, and ensure your medical records are complete before submitting any prior authorization request. 

If you qualify, Noom Med combines clinical evaluation, prescription access when appropriate, and support in navigating insurance and cost considerations as part of a coordinated care plan.